Evidence map›Paper›PMID 37425354›Full record

ArticleFrontiers in bioengineering and biotechnology2023

Nanofibers with homogeneous heparin distribution and protracted release profile for vascular tissue engineering.

Hongmei Zhang, Qilu Zhang, Juan Du, Tonghe Zhu, Dian Chen, Feiying Liu, Yang Dong

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Hongmei ZhangDepartment of Orthopedics Surgery, Shanghai Sixth People's Hospital Afffliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Qilu ZhangSchool of Textiles and Fashion, Shanghai University of Engineering Science, Shanghai, China.
Juan DuSchool of Chemistry and Chemical Engineering, Shanghai University of Engineering Science, Shanghai, China.
Tonghe ZhuDepartment of Orthopedics Surgery, Shanghai Sixth People's Hospital Afffliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Dian ChenDepartment of Cardiothoracic Surgery, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Feiying LiuSchool of Biotechnology, East China University of Science and Technology, Shanghai, China.
Yang DongDepartment of Orthopedics Surgery, Shanghai Sixth People's Hospital Afffliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shanghai Jiao Tong University · CNShanghai University of Engineering Science · CNEast China University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In clinic, controlling acute coagulation after small-diameter vessel grafts transplantation is considered a primary problem. The combination of heparin with high anticoagulant efficiency and polyurethane fiber with good compliance is a good choice for vascular materials. However, blending water-soluble heparin with fat-soluble poly (ester-ether-urethane) urea elastomer (PEEUU) uniformly and preparing nanofibers tubular grafts with uniform morphology is a huge challenge. In this research, we have compounded PEEUU with optimized constant concentration of heparin by homogeneous emulsion blending, then spun into the hybrid PEEUU/heparin nanofibers tubular graft (H-PHNF) for replacing rats' abdominal aorta

Indexed as

electrospun vascular graftsheparinmechanical compliancepatency ratethrombosis

Identifiers

PMID37425354
PMCPMC10324977
OpenAlexW4381929684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.